AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2016
Oct 4, 2016
31523_dirs_2016-10-04_f6bfb40f-a595-4727-843b-6ebc0209a5b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-10-03
Reporting Person: Do Hung (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-03 | Common Stock | S | 25000 | $7.25 | Disposed | 558453 | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.
F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.05 to $7.35. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.